Please login to the form below

Not currently logged in

Syros Pharmaceuticals

This page shows the latest Syros Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch January 2018

    Option, collaboration. 1, 063. Syros Pharmaceuticals/ Incyte. Gene control platform to identify up to seven therapeutic targets with a focus in myeloproliferative neoplasms. ... Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Syros appoints Moderna CEO to board Syros appoints Moderna CEO to board

    Stéphane Bancel also has experience at bioMérieux and Lilly. The founding CEO of Moderna Therapeutics, Stéphane Bancel, has joined the board of Syros Pharmaceuticals. ... Syros, which focuses on controlling a person's genes to treat cancer and other

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...